Cidara Therapeutics Stock Price

0.0086 (1.55%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 473,416
Bid Price 0.523
Ask Price 0.5635
News (4)
Day High 0.6307


52 Week Range


Day Low 0.5362
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cidara Therapeutics Inc CDTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0086 1.55% 0.5635 18:14:18
Open Price Low Price High Price Close Price Prev Close
0.5999 0.5362 0.6307 0.52 0.5549
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
733 473,416 $ 0.574768 $ 272,104 - 0.40 - 2.39
Last Trade Time Type Quantity Stock Price Currency
18:36:20 50 $ 0.5635 USD


Draw Mode:

Cidara Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 38.91M 69.05M 67.97M $ 49.57M $ -40.14M -0.86 -0.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -654.00 3.50%

more financials information »

Cidara Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CDTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.500.63070.43060.5061763322,0710.063512.7%
1 Month0.44420.63070.400.5025707349,9460.119326.86%
3 Months0.860.950.400.582391296,257-0.2965-34.48%
6 Months1.391.410.400.7952687327,258-0.8265-59.46%
1 Year1.932.390.401.36490,643-1.37-70.8%
3 Years1.674.450.402.15430,981-1.11-66.26%
5 Years7.008.800.402.58311,311-6.44-91.95%

Cidara Therapeutics Description

Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates.

Your Recent History
Cidara The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.